(Q37776723)

23 August 2017

1 reference

title

Plant-made pharmaceuticals for the prevention and treatment of autoimmune diseases: where are we? (English)

1 reference

23 August 2017

1

Linda Avesani

1 reference

23 August 2017

2

Luisa Bortesi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20673017

13 June 2024

3

Luca Santi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20673017

13 June 2024

author name string

Alberto Falorni

4

1 reference

23 August 2017

Mario Pezzotti

5

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20673017

13 June 2024

publication date

1 August 2010

1 reference

full work available at URL

23 August 2017

http://www.future-drugs.com/doi/abs/10.1586/erv.10.82

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20673017

http://www.tandfonline.com/doi/pdf/10.1586/erv.10.82

13 June 2024

1 reference

Expert Review of Vaccines

13 June 2024

published in

1 reference

23 August 2017

volume

9

1 reference

23 August 2017

issue

8

1 reference

23 August 2017

page(s)

957-969

1 reference

Checkpoints in lymphocyte development and autoimmune disease

23 August 2017

cites work

1 reference

Clustering and commonalities among autoimmune diseases

21 January 2018

1 reference

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

Immunotherapy of type 1 diabetes: where are we and where should we be going?

21 January 2018

1 reference

Evolving concepts of rheumatoid arthritis

21 January 2018

1 reference

Developments in the scientific understanding of rheumatoid arthritis

21 January 2018

1 reference

Current concepts in the pathogenesis of early rheumatoid arthritis

21 January 2018

1 reference

Inflammatory bowel disease: cause and immunobiology

21 January 2018

1 reference

Therapy with GAD in diabetes

21 January 2018

1 reference

GAD treatment and insulin secretion in recent-onset type 1 diabetes

21 January 2018

1 reference

The prospect of vaccination to prevent type 1 diabetes

21 January 2018

1 reference

Treating autoimmune diseases through restoration of antigen-specific immune tolerance

21 January 2018

1 reference

Oral immunization with hepatitis B surface antigen expressed in transgenic plants

21 January 2018

1 reference

Targeting of plant-derived vaccine antigens to immunoresponsive mucosal sites

21 January 2018

1 reference

Bioproduction of therapeutic proteins in the 21st century and the role of plants and plant cells as production platforms

21 January 2018

1 reference

Biosynthesis and periplasmic segregation of human proinsulin in Escherichia coli

21 January 2018

1 reference

Secretion and processing of insulin precursors in yeast

21 January 2018

1 reference

Processing of mutated proinsulin with tetrabasic cleavage sites to bioactive insulin in the non-endocrine cell line, COS-7.

21 January 2018

1 reference

Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds

21 January 2018

1 reference

Engineering and expression of the intracellular domain of insulinoma-associated tyrosine phosphatase (IA-2ic), a type 1 diabetes autoantigen, in plants.

21 January 2018

1 reference

Crystal structure and functional analysis of Escherichia coli glutamate decarboxylase

21 January 2018

1 reference

Improved in planta expression of the human islet autoantigen glutamic acid decarboxylase (GAD65).

21 January 2018

1 reference

Site-directed mutagenesis of K396R of the 65 kDa glutamic acid decarboxylase active site obliterates enzyme activity but not antibody binding.

21 January 2018

1 reference

A novel expression platform for the production of diabetes-associated autoantigen human glutamic acid decarboxylase (hGAD65).

21 January 2018

1 reference

Development and evaluation of transgenic rice seeds accumulating a type II-collagen tolerogenic peptide.

21 January 2018

1 reference

Transgenic mouse models of rheumatoid arthritis

21 January 2018

1 reference

Identification of tissue transglutaminase as the autoantigen of celiac disease

21 January 2018

1 reference

Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease

21 January 2018

1 reference

Production of recombinant human tissue transglutaminase using the baculovirus expression system, and its application for serological diagnosis of coeliac disease

21 January 2018

1 reference

Autoantibodies to human tissue transglutaminase: superior predictors of coeliac disease.

21 January 2018

1 reference

Expression in Escherichia coli and purification of hexahistidine-tagged human tissue transglutaminase

21 January 2018

1 reference

Recombinant human tissue transglutaminase produced into tobacco suspension cell cultures is active and recognizes autoantibodies in the serum of coeliac patients.

21 January 2018

1 reference

Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit

21 January 2018

1 reference

Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit

21 January 2018

1 reference

Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting

21 January 2018

1 reference

Expression of a ricin toxin B subunit: insulin fusion protein in edible plant tissues

21 January 2018

1 reference

A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes

21 January 2018

1 reference

Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts--oral administration protects against development of insulitis in non-obese diabetic mice

21 January 2018

1 reference

Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4.

21 January 2018

1 reference

Murine interleukin-4 displays potent anti-tumor activity in vivo

21 January 2018

1 reference

Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease

21 January 2018

1 reference

Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice

21 January 2018

1 reference

Expression, renaturation and purification of recombinant human interleukin 4 from Escherichia coli

21 January 2018

1 reference

Secretion of biologically active human interleukin-2 and interleukin-4 from genetically modified tobacco cells in suspension culture.

21 January 2018

1 reference

Production of biologically active human interleukin-4 in transgenic tobacco and potato.

21 January 2018

1 reference

Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice

21 January 2018

1 reference

Subcellular targeting of human interleukin-10 in plants

21 January 2018

1 reference

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

21 January 2018

1 reference

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

Viral and murine interleukin-10 are correctly processed and retain their biological activity when produced in tobacco

21 January 2018

1 reference

The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy

21 January 2018

1 reference

A novel platform for biologically active recombinant human interleukin-13 production

21 January 2018

1 reference

Plants as bioreactors: Recent developments and emerging opportunities

21 January 2018

1 reference

Magnifection--a new platform for expressing recombinant vaccines in plants

21 January 2018

1 reference

Immunization against rabies with plant-derived antigen

21 January 2018

1 reference

Plant-made vaccines for humans and animals.

21 January 2018

1 reference

Hydrophobin fusions for high-level transient protein expression and purification in Nicotiana benthamiana.

21 January 2018

1 reference

The human immunodeficiency virus antigen Nef forms protein bodies in leaves of transgenic tobacco when fused to zeolin

21 January 2018

1 reference

A self-contained system for the field production of plant recombinant interleukin-10

21 January 2018

1 reference

Therapeutic effectiveness of orally administered transgenic low-alkaloid tobacco expressing human interleukin-10 in a mouse model of colitis

21 January 2018

1 reference

Elastin-like polypeptide fusions enhance the accumulation of recombinant proteins in tobacco leaves

21 January 2018

1 reference

Persistence of physiological self antigen is required for the regulation of self tolerance

21 January 2018

4

1 reference

Human insulin from a precursor overexpressed in the methylotrophic yeast Pichia pastoris and a simple procedure for purifying the expression product

13 June 2024

21

1 reference

Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance

13 June 2024

27

1 reference

Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope

13 June 2024

34

1 reference

Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis

13 June 2024

38

1 reference

Immunohistochemical study on type II collagen-induced arthritis in DBA/1J mice

13 June 2024

42

1 reference

Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 mice

13 June 2024

43

1 reference

Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen

13 June 2024

45

1 reference

Molecular farming of human tissue transglutaminase in tobacco plants

13 June 2024

53

1 reference

Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA

13 June 2024

55

1 reference

Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants

13 June 2024

61

1 reference

Plasmid vaccination with insulin B chain prevents autoimmune diabetes in nonobese diabetic mice

13 June 2024

62

1 reference

Purification and characterization of recombinant human interleukin 4. Biological activities, receptor binding and the generation of monoclonal antibodies

13 June 2024

69

1 reference

Psoriasis and the new biologic agents: interrupting a T-AP dance

13 June 2024

73

1 reference

Validation of the interleukin-10 knockout mouse model of colitis: antitumour necrosis factor-antibodies suppress the progression of colitis

13 June 2024

77

1 reference

European Cytokine Network

13 June 2024

80

11

153

Wakkach

2000

1 reference

Interleukin-13 prevents autoimmune diabetes in NOD mice

13 June 2024

83

1 reference

pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants

13 June 2024

89

1 reference

Forcing single-chain variable fragment production in tobacco seeds by fusion to elastin-like polypeptides

13 June 2024

92

1 reference

13 June 2024

Identifiers

DOI

10.1586/ERV.10.82

1 reference

23 August 2017

1 reference